THE USE OF BIOSORBENTS IN HEMATOLOGY AND THEIR EFFECTS ON CARDIAC FUNCTION
Abstract
This article provides a comprehensive study of the use of biosorbents in hematology and their effects on cardiac function. Biosorbents, which can be natural or synthetic materials, possess the ability to adsorb toxins, excess lipids, and other harmful substances from the blood. These properties contribute to blood purification, stabilization of hemoglobin levels, and improvement of red and white blood cell function. Furthermore, biosorbents help regulate lipid profiles, reduce cholesterol and triglyceride levels, and support cardiovascular health. The article analyzes various research findings, highlighting the positive effects of biosorbents on heart function and circulatory system by reducing toxic load in the blood. Long-term use of biosorbents is shown to be effective in stabilizing hematological parameters and decreasing the risk of cardiovascular diseases. These findings suggest potential applications of biosorbents in clinical practice for both hematological and cardiological preventive strategies.
References
1. Marijana Matejic Spasic, Sandra Lindstedt, Guillaume Lebreton, va boshqalar. The role of hemoadsorption in cardiac surgery – a systematic review. BMC Cardiovascular Disorders, 2024. BioMed Central+1
2. Hemoadsorption use in adult cardiac surgery for infective endocarditis: A comprehensive meta analysis. PubMed, 2024. PubMed
3. Cytokine Hemoadsorption During Cardiac Surgery Versus Standard Surgical Care for Infective Endocarditis (REMOVE): Multicenter RCT. Critical Care, 2022/2023. PubMed
4. Cytokine clearance with CytoSorb® during cardiac surgery: a pilot randomized controlled trial. Critical Care, 2019. BioMed Central
5. Cytokine hemoadsorption with CytoSorb® in post cardiac arrest syndrome, a pilot randomized controlled trial. Critical Care, 2023. BioMed Central
6. Hemoadsorption efficacy for uncomplicated high-risk cardiac surgery. Critical Care, 2019 (letter / comment). BioMed Central
7. Effect of hemoadsorption during cardiopulmonary bypass surgery – a blinded, randomized, controlled pilot study. Critical Care, 2016. BioMed Central
8. Use of CytoSorb® hemoadsorption column during prolonged cardiopulmonary bypass in complex cardiac surgery patient. Journal of Cardiothoracic Surgery, 2022. BioMed Central
9. Hemadsorption with CytoSorb®: focus on the latest experiences in cardiac surgery patients. Narrative review, PubMed, 2024. PubMed




















